Mesenchymal stem cells for the treatment of CNS diseases
US8900574B2 · kind B2 · utility
5Cited by
10References
4Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Jan 27, 2014 |
| Grant date | Dec 2, 2014 |
| Priority date | — |
| Expiry date | Jan 27, 2034 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2506/1353
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
An isolated human cell is disclosed comprising at least one mesenchymal stem cell phenotype and secreting brain-derived neurotrophic factor (BDNF), wherein a basal secretion of the BDNF is at least five times greater than a basal secretion of the BDNF in a mesenchymal stem cell. Methods of generating same and uses of same are also disclosed.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.